Flubrotizolam
From Wikipedia, the free encyclopedia
Thienotriazolodiazepine
![]() | |
Identifiers | |
---|---|
IUPAC name
| |
CAS Number | |
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C15H10BrFN4S |
Molar mass | 377.24 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
Flubrotizolam (2-bromo-4-(2-fluorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine) is a thienotriazolodiazepine derivative with potent sedative and anxiolytic effects, which has been sold as a designer drug.[1][2]
See also[]
- Brotizolam
- Flubromazolam
- Fluclotizolam
- Etizolam
References[]
- ^ US 4094984, Weber KH, Bauer A, Danneburg P, Kuhn FJ, "6-Phenyl-8-bromo-4H-s-triazolo-[3,4C]-thieno-[2,3E]-1,4-diazepines and salts thereof.", issued 13 June 1978, assigned to Boehringer Ingelheim
- ^ Catalani V, Botha M, Corkery JM, Guirguis A, Vento A, Scherbaum N, Schifano F (July 2021). "The Psychonauts' Benzodiazepines; Quantitative Structure-Activity Relationship (QSAR) Analysis and Docking Prediction of Their Biological Activity". Pharmaceuticals. Basel, Switzerland. 14 (8): 720. doi:10.3390/ph14080720. PMC 8398354. PMID 34451817.
Benzodiazepines | |
---|---|
1,4-Benzodiazepines |
|
1,5-Benzodiazepines |
|
2,3-Benzodiazepines* |
|
Triazolobenzodiazepines |
|
Imidazobenzodiazepines |
|
Oxazolobenzodiazepines |
|
Thienodiazepines | |
Thienotriazolodiazepines |
|
Thienobenzodiazepines* | |
Pyridodiazepines |
|
Pyridotriazolodiazepines |
|
Pyrazolodiazepines | |
Pyrrolodiazepines | |
Tetrahydroisoquinobenzodiazepines | |
Pyrrolobenzodiazepines* |
|
Benzodiazepine prodrugs |
|
* atypical activity profile (not GABAA receptor ligands) |
Hypnotics/sedatives (N05C) | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GABAA |
| ||||||||||||||||||||||||
GABAB |
| ||||||||||||||||||||||||
H1 |
| ||||||||||||||||||||||||
α2-Adrenergic |
| ||||||||||||||||||||||||
5-HT2A |
| ||||||||||||||||||||||||
Melatonin |
| ||||||||||||||||||||||||
Orexin |
| ||||||||||||||||||||||||
α2δ VDCC |
| ||||||||||||||||||||||||
Others |
|
GABAA receptor positive modulators | |
---|---|
Alcohols |
|
Barbiturates |
|
Benzodiazepines |
|
Carbamates |
|
Flavonoids |
|
Imidazoles |
|
Kava constituents |
|
Monoureides |
|
Neuroactive steroids |
|
Nonbenzodiazepines |
|
Phenols |
|
Piperidinediones |
|
Pyrazolopyridines |
|
Quinazolinones |
|
Volatiles/gases |
|
Others/unsorted |
|
See also: Receptor/signaling modulators • GABA receptor modulators • GABA metabolism/transport modulators |
![]() | This pharmacology-related article is a stub. You can help Wikipedia by . |
- v
- t
Retrieved from ""
Categories:
- Designer drugs
- GABAA receptor positive allosteric modulators
- Heterocyclic compounds with 3 rings
- Nitrogen heterocycles
- Sulfur heterocycles
- Bromoarenes
- Fluoroarenes
- Pharmacology stubs
Hidden categories:
- Articles with short description
- Short description is different from Wikidata
- Infobox drug articles with non-default infobox title
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- All stub articles